UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
CJ Healthcare secures state support for new drug to treat rheumatoid arthritis
CJ Healthcare said Wednesday it has secured the government’s support to dev...
by Lee Han-soo
|
2017-08-30 14:20
라인
Terminally-ill patients protest HIRA’s latest ban on off-label prescriptions on immune checkpoint inhibitors
“Withdraw your decision to ban off-label prescriptions on immune checkpoint...
by Yang Geum-deok
|
2017-08-30 14:07
라인
Dong-A ST, Takeda to jointly sell hypertension pill ‘Edarbi’ in Korea
Dong-A ST and Takeda Pharmaceuticals Korea have signed an agreement to join...
by Lee Han-soo
|
2017-08-30 13:54
라인
GSK tops clinical trial transparency
GlaxoSmithKline said it ranked No.1 out of 46 pharmaceutical companies in c...
by Marian Chu
|
2017-08-30 11:56
라인
Cho-A Pharma awarded gold for children’s multi-vitamin drink
Cho-A Pharmaceutical's children's multi-vitamin drink Jalkton won t...
by Constance Williams
|
2017-08-30 11:28
라인
FDA approves first treatment for Chagas disease
The U.S. Food and Drug Administration has approved benznidadzole to be used...
by Lee Han-soo
|
2017-08-30 11:19
라인
Gilead to acquire Kite Pharma for $11.9 billion
Gilead, the developer of blockbuster hepatitis C and HIV treatments, said M...
by Marian Chu
|
2017-08-30 11:09
라인
Healthcare benefits for immune checkpoint inhibitor Tecentrqi, unclear
Roche’s immune checkpoint inhibitor Tecentriq (Atezolizumab) might have a d...
by Park Gi-taek
|
2017-08-30 10:17
라인
Hanmi plans to release Tefovir early October
Hanmi Pharmaceutical said Tuesday it will release Tefovir Tab (compound: te...
by Lee Hye-seon
|
2017-08-29 17:12
라인
Hanall, Daewoong develop new drug for dry eye treatment
Hanall Biopharma and Daewoong Pharmaceutical said they filed an investigati...
by Marian Chu
|
2017-08-29 16:50
라인
Upgraded hypertension pill ‘Telminuvo’ obtains patent
Korean pharmaceutical firm Chong Kun Dang said on Tuesday it has obtained p...
by Lee Han-soo
|
2017-08-29 16:41
라인
Legal disputes between PMG Pharm, generics firms intensify over Layla
Legal disputes between PMG Pharm Korea and generics companies including Mot...
by Lee Hye-seon
|
2017-08-29 16:25
라인
Sanofi Pasteur launches new quadrivalent influenza vaccine
Sanofi Pasteur Korea, the vaccines division of the French multinational pha...
by Marian Chu
|
2017-08-29 14:14
라인
GemVax & Kael preps for P2 of Alzheimer's treatment
Korean biopharmaceutical firm GemVax & Kael said it has started to recruit ...
by Constance Williams
|
2017-08-29 11:49
라인
JW CreaGene gets state funding to treat aggressive brain tumor
JW CreaGene said Tuesday it has secured a government funding to implement c...
by Marian Chu
|
2017-08-29 11:37
라인
CMG Pharma to export erectile dysfunction drug to Philippines
CMG Pharmaceuticals, an affiliate company of CHA Health Systems that specia...
by Constance Williams
|
2017-08-28 16:04
라인
16 local pharmaceutical firms obtain preferential rights to sell Viread
Sixteen Korean pharmaceutical companies obtained preferential rights from t...
by Lee Hye-seon
|
2017-08-28 14:22
라인
SK Chem supplies world’s first quadrivalent flu vaccine
SK Chemicals said Monday it has started supplying the world's first qua...
by Constance Williams
|
2017-08-28 11:54
라인
‘Let's protect patients until complete cure of hepatitis B comes’
"In the next 15 to 20 years, we will be able to cure chronic hepatitis B co...
by Park Gi-taek
|
2017-08-28 10:46
라인
Allergan Korea gains marketing approval for double chin treatment
Allergan Korea said Friday it received the Ministry of Food and Drug Safety...
by Marian Chu
|
2017-08-28 10:42
-
이전
111
112
113
114
115
116
117
118
119
120
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top